Retrieve available abstracts of 65 articles: HTML format
Single Articles
December 2025
NASH Z, Christmas M, Gronlund T, Hickey M, et al Top ten menopause research priorities.
Lancet. 2025;404:2535-2536. PubMed
July 2025
BRASIL P, Nielsen-Saines K, Guaraldo L, Fuller T, et al A decade later, what have we learned from the Zika epidemic in children with
intrauterine exposure?
Lancet. 2025 Jul 3:S0140-6736(25)00826-8. doi: 10.1016/S0140-6736(25)00826. PubMedAbstract available
June 2025
HARTER P, Marme F Targeting the glucocorticoid receptor in relapsed ovarian cancer: a new pathway
and standard treatment option in ovarian cancer.
Lancet. 2025;405:2180-2182. PubMed
DE SMIT NS, de Lange ME, Boomsma MF, Huirne JAF, et al Current treatment for symptomatic uterine fibroids: available evidence and
therapeutic dilemmas.
Lancet. 2025 Jun 19:S0140-6736(25)00728-7. doi: 10.1016/S0140-6736(25)00728. PubMedAbstract available
FERNANDEZ TURIENZO C, November L, Kamara M, Conteh O, et al Community-based mentoring to reduce maternal and perinatal mortality in
adolescent pregnancies in Sierra Leone (2YoungLives): a pilot cluster-randomised
controlled trial.
Lancet. 2025 Jun 18:S0140-6736(25)00454-4. doi: 10.1016/S0140-6736(25)00454. PubMedAbstract available
HODNETT E A community-based landmark trial to save the lives of pregnant adolescents and
their newborns in sub-Saharan Africa.
Lancet. 2025 Jun 18:S0140-6736(25)00731-7. doi: 10.1016/S0140-6736(25)00731. PubMed
OLAWAIYE AB, Gladieff L, O'Malley DM, Kim JW, et al Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian
cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial.
Lancet. 2025 Jun 2:S0140-6736(25)01040-2. doi: 10.1016/S0140-6736(25)01040. PubMedAbstract available
May 2025
SCHOENAKER D, Stephenson J, Chakrabarti S, Alloway L, et al Prioritising maternal health must include care before pregnancy.
Lancet. 2025;405:1903. PubMed
GARDOSI J, Ewington LJ, Booth K, Bick D, et al Induction of labour versus standard care to prevent shoulder dystocia in fetuses
suspected to be large for gestational age in the UK (the Big Baby trial): a
multicentre, open-label, randomised controlled trial.
Lancet. 2025 May 1:S0140-6736(25)00162-X. doi: 10.1016/S0140-6736(25)00162. PubMedAbstract available
March 2025
LAUDANSKI P Natural or artificial menstrual cycle for frozen embryo transfer.
Lancet. 2025;405:893-894. PubMed
MAKAMA M, Vogel JP Atosiban and managing women in preterm labour.
Lancet. 2025 Mar 3:S0140-6736(25)00402-7. doi: 10.1016/S0140-6736(25)00402. PubMed
February 2025
RAHIM MN, Williamson C, Kametas NA, Heneghan MA, et al Pregnancy and the liver.
Lancet. 2025;405:498-513. PubMedAbstract available
HUGHES H Endometriosis: an Australian perspective on encouraging change.
Lancet. 2025;405:378-379. PubMed
DANG L, Mi M, Qiao Y, Zhu L, et al Eliminating cervical cancer in the Tibetan Plateau.
Lancet. 2025;405:375-376. PubMed
November 2024
LORUSSO D, Yamada K, Li K, Cerrotta A, et al Pembrolizumab for locally advanced cervical cancer - Authors' reply.
Lancet. 2024;404:2051-2052. PubMed
DONG B, Lu Y, Wang Y, Sun P, et al Pembrolizumab for locally advanced cervical cancer.
Lancet. 2024;404:2050. PubMed
SCHMID MP, Petric P, Mahantshetty U, Kirisits C, et al Pembrolizumab for locally advanced cervical cancer.
Lancet. 2024;404:2050-2051. PubMed
KAMRAVA M, Beriwal S Pembrolizumab for locally advanced cervical cancer.
Lancet. 2024;404:2049. PubMed
MURAKAMI N, Okonogi N, Terao Y, Shikama N, et al Pembrolizumab for locally advanced cervical cancer.
Lancet. 2024;404:2049-2050. PubMed
Global, regional, and national stillbirths at 20 weeks' gestation or longer in
204 countries and territories, 1990-2021: findings from the Global Burden of
Disease Study 2021.
Lancet. 2024 Nov 4:S0140-6736(24)01925-1. doi: 10.1016/S0140-6736(24)01925. PubMedAbstract available
October 2024
MCCORMACK M, Eminowicz G, Gallardo D, Diez P, et al Induction chemotherapy followed by standard chemoradiotherapy versus standard
chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG
INTERLACE): an international, multicentre, randomised phase 3 trial.
Lancet. 2024;404:1525-1535. PubMedAbstract available
DUSKA LR, Randall LM Progress in the treatment paradigms for locally advanced cervical cancer.
Lancet. 2024;404:1494-1496. PubMed
WU X, Sun Y, Yang H, Wang J, et al Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as
first-line treatment for persistent, recurrent, or metastatic cervical cancer
(COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in
China.
Lancet. 2024 Oct 15:S0140-6736(24)02135-4. doi: 10.1016/S0140-6736(24)02135. PubMedAbstract available
SUN C, Ma D Embracing more treatment choices for metastatic, recurrent, or persistent
cervical cancer.
Lancet. 2024 Oct 15:S0140-6736(24)02196-2. doi: 10.1016/S0140-6736(24)02196. PubMed
THE LANCET Endometriosis: addressing the roots of slow progress.
Lancet. 2024;404:1279. PubMed
September 2024
SHARP G, Randhawa A, Fernando AN Reflections on The Lancet menopause Series.
Lancet. 2024 Sep 25:S0140-6736(24)01710-0. doi: 10.1016/S0140-6736(24)01710. PubMed
BROWN L, Hunter MS, Crandall CJ, Connors HJ, et al Reflections on The Lancet menopause Series - Authors' reply.
Lancet. 2024 Sep 25:S0140-6736(24)01712-4. doi: 10.1016/S0140-6736(24)01712. PubMed
STUCKEY BGA Reflections on The Lancet menopause Series.
Lancet. 2024 Sep 25:S0140-6736(24)01709-4. doi: 10.1016/S0140-6736(24)01709. PubMed
XIAO Y, Shen M, Chen X Reflections on The Lancet menopause Series.
Lancet. 2024 Sep 25:S0140-6736(24)01711-2. doi: 10.1016/S0140-6736(24)01711. PubMed
GENNIGENS C Hope emerging in the locally advanced cervical cancer landscape.
Lancet. 2024 Sep 13:S0140-6736(24)01918-4. doi: 10.1016/S0140-6736(24)01918. PubMed
LORUSSO D, Xiang Y, Hasegawa K, Scambia G, et al Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or
placebo for newly diagnosed, high-risk, locally advanced cervical cancer
(ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised,
double-blind, placebo-
Lancet. 2024 Sep 13:S0140-6736(24)01808-7. doi: 10.1016/S0140-6736(24)01808. PubMedAbstract available
August 2024
RYDELIUS J, Hognert H, Kopp-Kallner H, Brandell K, et al First dose of misoprostol administration at home or in hospital for medical
abortion between 12-22 gestational weeks in Sweden (PRIMA): a multicentre,
open-label, randomised controlled trial.
Lancet. 2024;404:864-873. PubMedAbstract available
MOSESON H, Gerdts C Expanding access, reducing burdens, and improving person-centred care in
abortion.
Lancet. 2024;404:826-827. PubMed
FIGUERAS F, Rial-Crestelo M, Gratacos E Cerebroplacental ratio in low-risk pregnancies: the RATIO37 trial - Authors'
reply.
Lancet. 2024;404:751-752. PubMed
GILES-CLARK HJ, Rolnik DL, Hodges RJ, Skinner SM, et al Cerebroplacental ratio in low-risk pregnancies: the RATIO37 trial.
Lancet. 2024;404:750. PubMed
BACON I, Hezelgrave NL, Cerdeira AS, Mylrea-Foley B, et al Cerebroplacental ratio in low-risk pregnancies: the RATIO37 trial.
Lancet. 2024;404:750-751. PubMed
KAMIHARA Y, Nagase H, Ishikawa H Cerebroplacental ratio in low-risk pregnancies: the RATIO37 trial.
Lancet. 2024;404:749-750. PubMed
MEIJERINK L, Terstappen F, Depmann M, Bekker M, et al Cerebroplacental ratio in low-risk pregnancies: the RATIO37 trial.
Lancet. 2024;404:749. PubMed
BORNSTEIN E, Vintzileos A Cerebroplacental ratio in low-risk pregnancies: the RATIO37 trial.
Lancet. 2024;404:748-749. PubMed
WEI F, Georges D, Man I, Baussano I, et al Causal attribution of human papillomavirus genotypes to invasive cervical cancer
worldwide: a systematic analysis of the global literature.
Lancet. 2024;404:435-444. PubMedAbstract available
SCHIFFMAN M, de Sanjose S The rational design of cervical cancer prevention strategies.
Lancet. 2024;404:406-407. PubMed
July 2024
ALVES L New abortion bill in Brazil sparks backlash.
Lancet. 2024;404:17. PubMed
June 2024
HO VNA, Pham TD, Nguyen NT, Wang R, et al Livebirth rate after one frozen embryo transfer in ovulatory women starting with
natural, modified natural, or artificial endometrial preparation in Viet Nam: an
open-label randomised controlled trial.
Lancet. 2024 Jun 26:S0140-6736(24)00756-6. doi: 10.1016/S0140-6736(24)00756. PubMedAbstract available
JAFFE S US Supreme Court protects access to abortion medication.
Lancet. 2024;403:2679-2680. PubMed
SWEETING A, Hannah W, Backman H, Catalano P, et al Epidemiology and management of gestational diabetes.
Lancet. 2024 Jun 18:S0140-6736(24)00825-0. doi: 10.1016/S0140-6736(24)00825. PubMedAbstract available
HIVERT MF, Backman H, Benhalima K, Catalano P, et al Pathophysiology from preconception, during pregnancy, and beyond.
Lancet. 2024 Jun 18:S0140-6736(24)00827-4. doi: 10.1016/S0140-6736(24)00827. PubMedAbstract available
May 2024
SAMARASINGHE SNS, Leca B, Alabdulkader S, Dimitriadis GK, et al Bariatric surgery for spontaneous ovulation in women living with polycystic ovary
syndrome: the BAMBINI multicentre, open-label, randomised controlled trial.
Lancet. 2024 May 20:S0140-6736(24)00538-5. doi: 10.1016/S0140-6736(24)00538. PubMedAbstract available
MORIN-PAPUNEN L Bariatric surgery in women with PCOS and obesity.
Lancet. 2024 May 20:S0140-6736(24)00811-0. doi: 10.1016/S0140-6736(24)00811. PubMed
April 2024
STRAND TA, McCann A, Kvestad I, Chandyo RK, et al Vitamin B12 deficiency in pregnant women - Authors' reply.
Lancet. 2024;403:1450. PubMed
SEN S Vitamin B12 deficiency in pregnant women.
Lancet. 2024;403:1449-1450. PubMed
March 2024
JOHANSSON K, Bodnar LM, Stephansson O, Abrams B, et al Safety of low weight gain or weight loss in pregnancies with class 1, 2, and 3
obesity: a population-based cohort study.
Lancet. 2024 Mar 28:S0140-6736(24)00255-1. doi: 10.1016/S0140-6736(24)00255. PubMedAbstract available
GAILLARD R Optimising gestational weight gain among pregnant women with obesity.
Lancet. 2024 Mar 28:S0140-6736(24)00470-7. doi: 10.1016/S0140-6736(24)00470. PubMed
LORUSSO D, Xiang Y, Hasegawa K, Scambia G, et al Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or
placebo for newly diagnosed, high-risk, locally advanced cervical cancer
(ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical
trial.
Lancet. 2024 Mar 20:S0140-6736(24)00317-9. doi: 10.1016/S0140-6736(24)00317. PubMedAbstract available
TEWARI KS, Monk BJ Immunotherapy plus chemoradiotherapy in cervical cancer management.
Lancet. 2024 Mar 20:S0140-6736(24)00468-9. doi: 10.1016/S0140-6736(24)00468. PubMed
HEISLER M, Mitchell N, Arey W, Erenberg M, et al US abortion bans should not pre-empt the duty to provide life-saving abortion
care to pregnant patients in medical emergencies.
Lancet. 2024 Mar 19:S0140-6736(24)00551-8. doi: 10.1016/S0140-6736(24)00551. PubMed
DADOUN S, Demmler-Harrison GJ, Ketwaroo P, Castro EC, et al Congenital toxoplasmosis of the brain caused by infection in late pregnancy.
Lancet. 2024;403:1081-1082. PubMed
MISHRA GD, Davies MC, Hillman S, Chung HF, et al Optimising health after early menopause.
Lancet. 2024;403:958-968. PubMedAbstract available
HICKEY M, Basu P, Sassarini J, Stegmann ME, et al Managing menopause after cancer.
Lancet. 2024;403:984-996. PubMedAbstract available
BROWN L, Hunter MS, Chen R, Crandall CJ, et al Promoting good mental health over the menopause transition.
Lancet. 2024;403:969-983. PubMedAbstract available
HICKEY M, LaCroix AZ, Doust J, Mishra GD, et al An empowerment model for managing menopause.
Lancet. 2024;403:947-957. PubMedAbstract available
HAWKES P, Scott J, Hickey M 500 Strong: celebrating older women's bodies in menopause and beyond.
Lancet. 2024;403:894-903. PubMed
SAMARASEKERA U Martha Hickey: responding to the complexity of menopause.
Lancet. 2024;403:893. PubMed
THE LANCET Time for a balanced conversation about menopause.
Lancet. 2024;403:877. PubMed
NIELSEN OH, Gubatan JM, Kolho KL, Streett SE, et al Updates on the management of inflammatory bowel disease from periconception to
pregnancy and lactation.
Lancet. 2024 Mar 5:S0140-6736(24)00052-7. doi: 10.1016/S0140-6736(24)00052. PubMedAbstract available
ZAROCOSTAS J Renewed calls to scale-up cervical cancer screening.
Lancet. 2024;403:797. PubMed